Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $2.40
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 0
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 141.95
Closing Price Change $ 2.40
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 1,246.00m
RiskGrade 120

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 5
Sell 1
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 02-Feb-2026

Time Volume / Share Price
15:45 100 @ $142.69
15:45 100 @ $142.71
15:45 104 @ $142.69
15:45 100 @ $142.68
15:45 294 @ $142.68

Top of Page